 NEW YORK, May 25, 2021 PRNewswire -- BrainStorm Cell Therapeutics Inc. NASDAQ: BCLI, a leading developer of cellular therapies for neurodegenerative diseases, announced the presentation today of a poster titled, Molecular Mechanisms Underlying MSC-NTF NurOwn Exosome Benefits in a Mouse LPS-induced ARDS Model at the ISCT 2021 New Orleans VIRTUAL Meeting, being held from May 25-28, 2021. The poster will be presented during Virtual Poster Hall Session 2: May 25, 20:00-21:30 EDT. 